moclobemide has been researched along with clomipramine in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.89) | 18.7374 |
| 1990's | 28 (73.68) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 4 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Guelfi, JD; Roth, M | 1 |
| Fermanian, J; Guelfi, JD; Manfredi, R; Payan, C; Pedarriosse, AM | 1 |
| Anderson, J; Bille, A; Christensen, EM; Gjerris, A; Holm, P; Høyer, E; Jensen, H; Langagergaard, A; Larsen, JK; Mejlhede, A | 1 |
| Funke, HJ; Hellstern, K; Malanowski, H; Moritz, E | 1 |
| Allen, SR; Cervera, S; Civeira, J; Giner, J; Hellstern, K; Klar, K; Malanowski, H; Wirz, R | 1 |
| Berger, M; Burton, P; Cattiez, P; Defleur, J; Dierick, M; Franck, G; Hellstern, K; Hermans, W; Roelandts, A; Wolfrum, C | 1 |
| Berlin, I; Cournot, A; Manfredi, R; Molinier, P; Pedarriosse, AM; Puech, AJ; Zimmer, R | 1 |
| Holm, P; Karlsson, A; Koczkas, C; Nagy, A; Ose, E; Pétursson, H; Ulverås, L; Wenedikter, O | 1 |
| Holm, P; Høyer, E; Larsen, JK; Mejlhede, A; Mikkelsen, PL; Olesen, A; Schaumburg, E | 1 |
| Holm, P; Larsen, JK; Mikkelsen, PL | 1 |
| Hackett, LP; Ilett, KF; Pinder, M; Power, BM | 1 |
| Andersen, JV; Buch, D; Kragh-Sørensen, P; Müller, B; Stage, KB | 1 |
| Hernandez, AF; Montero, MN; Pla, A; Villanueva, E | 1 |
| Neuvonen, PJ; Pohjola-Sintonen, S; Tacke, U; Vuori, E | 1 |
| Aymard, N; Carbuccia, I; Honore, P | 1 |
| Lövheim, O; Mjörndal, T; Spigset, O | 1 |
| Møller, SE | 1 |
| Iwersen, S; Schmoldt, A | 1 |
| Lecrubier, Y; Payan, C; Pedarriosse, AM; Schmid-Burgk, W; Stabl, M | 1 |
| Desachy, A; François, B; Gastinne, H; Lachatre, G; Marquet, P; Roustan, J | 1 |
| Bech, P; Gjerris, A; Kragh-Sørensen, P; Larsen, JK; Nair, NP; Stage, KB | 1 |
| Ferrer-Dufol, A; Marques-Alamo, JM; Murillo, EC; Perez-Aradros, C | 1 |
| Gillman, PK | 1 |
| Stein, MB | 1 |
| Finge, T; Lambert, J; Malavialle, C | 1 |
| Dufour, H; Fermanian, J; Jouvent, R; Le Houezec, J; Mikkelsen, H; Millet, V; Payan, C | 1 |
| Ballon, N; Bange, F; Dardennes, RM; Even, C | 1 |
| Meyers, BS | 1 |
| Dahl, AA; Krüger, MB | 1 |
| Advenier, C; Alvarez, JC; Sanceaume, M; Spreux-Varoquaux, O | 1 |
| Stage, KB | 1 |
| Bech, P; Gram, LF; Larsen, JK; Stage, KB; Vestergaard, P | 1 |
2 review(s) available for moclobemide and clomipramine
| Article | Year |
|---|---|
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 1998 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
19 trial(s) available for moclobemide and clomipramine
| Article | Year |
|---|---|
The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Depressive Disorder; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors | 1992 |
Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Prospective Studies; Psychiatric Status Rating Scales | 1992 |
Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Isocarboxazid; Male; Middle Aged; Moclobemide; Psychiatric Status Rating Scales | 1991 |
Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
Topics: Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Germany; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales | 1990 |
Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Topics: Adult; Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Spain | 1990 |
Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Topics: Antidepressive Agents; Belgium; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales | 1990 |
Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects.
Topics: Adult; Affect; Attention; Autonomic Nervous System; Benzamides; Clomipramine; Drug Interactions; Ethanol; Flicker Fusion; Humans; Male; Memory; Moclobemide; Monoamine Oxidase Inhibitors; Psychomotor Performance | 1990 |
Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Psychiatric Status Rating Scales; Random Allocation | 1989 |
Moclobemide and clomipramine in reactive depression. A placebo-controlled randomized clinical trial.
Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents; Benzamides; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Psychiatric Status Rating Scales; Random Allocation | 1989 |
Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
Topics: Adult; Aged; Benzamides; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Random Allocation; Time Factors; Tremor | 1984 |
Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Family Practice; Female; Humans; Male; Middle Aged; Moclobemide; Patient Dropouts; Patient Selection; Psychiatric Status Rating Scales | 1995 |
Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
Topics: Adult; Aged; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Inventory; Single-Blind Method | 1993 |
Plasma amino acid profiles in relation to clinical response to moclobemide in patients with major depression. Danish University Antidepressant Group.
Topics: Adult; Aged; Amino Acids; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Inventory; Tryptophan; Tyrosine | 1993 |
Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
Topics: Adolescent; Adult; Aged; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Treatment Outcome | 1995 |
The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group.
Topics: Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Humans; Isocarboxazid; Moclobemide; Nortriptyline; Observer Variation; Personality Inventory; Psychometrics; Reproducibility of Results | 1997 |
Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
Topics: Adult; Affective Symptoms; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Chi-Square Distribution; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Hypokinesia; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Time Factors; Treatment Outcome | 1998 |
The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
Topics: Adult; Aged; Benzamides; Chi-Square Distribution; Chronic Disease; Clomipramine; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Moclobemide; Prospective Studies; Severity of Illness Index | 2005 |
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Principal Component Analysis | 2012 |
17 other study(ies) available for moclobemide and clomipramine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Disseminated Intravascular Coagulation; Drug Overdose; Fatal Outcome; Female; Fever; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Multiple Organ Failure; Selective Serotonin Reuptake Inhibitors; Syndrome | 1995 |
Fatal moclobemide overdose or death caused by serotonin syndrome?
Topics: Adult; Antidepressive Agents; Benzamides; Cause of Death; Clomipramine; Drug Interactions; Drug Overdose; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Psychotropic Drugs; Serotonin; Suicide; Syndrome | 1995 |
Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses.
Topics: Adult; Benzamides; Citalopram; Clomipramine; Drug Interactions; Drug Overdose; Fatal Outcome; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Serotonin | 1993 |
Determination of 5-hydroxytryptamine and tryptophan by liquid chromatography in whole blood. Its interest for the exploration of mental disorders.
Topics: Adult; Antidepressive Agents, Tricyclic; Benzamides; Chromatography, High Pressure Liquid; Clomipramine; Depressive Disorder; Female; Humans; Indicators and Reagents; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Serotonin; Spectrometry, Fluorescence; Tryptophan | 1994 |
Serotonin syndrome caused by a moclobemide-clomipramine interaction.
Topics: Aged; Benzamides; Clomipramine; Drug Interactions; Female; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Muscular Diseases; Serotonin; Syndrome | 1993 |
Three suicide attempts with moclobemide.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Drug Interactions; Drug Overdose; Female; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Suicide, Attempted | 1996 |
Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association.
Topics: Antidepressive Agents; Benzamides; Clomipramine; Drug Interactions; Drug Overdose; Female; Humans; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1997 |
Fatal serotonin syndrome caused by moclobemide-clomipramine overdose.
Topics: Adult; Benzamides; Clomipramine; Clorazepate Dipotassium; Drug Interactions; Drug Overdose; Fatal Outcome; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
Serotonin syndrome--clomipramine too soon after moclobemide?
Topics: Adult; Benzamides; Central Nervous System Diseases; Clomipramine; Depressive Disorder; Drug Interactions; Female; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Time Factors | 1997 |
[Fatal form of serotonin syndrome].
Topics: Adult; Benzamides; Clomipramine; Fatal Outcome; Female; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome | 1997 |
Serotonin syndrome caused by a clomipramine-moclobemide interaction.
Topics: Adult; Benzamides; Central Nervous System Diseases; Clomipramine; Confusion; Drug Interactions; Female; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Serotonin; Syndrome | 1998 |
Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Brain; Caudate Nucleus; Clomipramine; Drug Administration Schedule; Fluoxetine; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred Strains; Moclobemide; Raphe Nuclei; Serotonin; Time Factors; Tryptophan | 1999 |